Contribution of Maternal Antiretroviral Therapy and Breastfeeding to 24-Month Survival in Human Immunodeficiency Virus-Exposed Uninfected Children: An Individual Pooled Analysis of African and Asian Studies
Author(s) -
Shino Arikawa,
Nigel Rollins,
Gonzague Jourdain,
Jean H. Humphrey,
Athena P. Kourtis,
Irving Hoffman,
Max Essex,
Tim Farley,
Hoosen Coovadia,
Glenda Gray,
Louise Kuhn,
Roger Shapiro,
Valériane Leroy,
Robert C. Bollinger,
Carolyne OnyangoMakumbi,
Shahin Lockman,
Carina Marquez,
Tanya Doherty,
François Dabis,
Laurent Mandelbrot,
Sophie Le Cœur,
Matthieu Rolland,
Pierre Joly,
MarieLouise Newell,
Renaud Becquet
Publication year - 2017
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cix1102
Subject(s) - breastfeeding , medicine , hazard ratio , proportional hazards model , infant mortality , population , child mortality , breast feeding , confidence interval , pediatrics , cumulative incidence , relative risk , demography , survival analysis , environmental health , cohort , sociology
Human immunodeficiency virus (HIV)-infected pregnant women increasingly receive antiretroviral therapy (ART) to prevent mother-to-child transmission (PMTCT). Studies suggest HIV-exposed uninfected (HEU) children face higher mortality than HIV-unexposed children, but most evidence relates to the pre-ART era, breastfeeding of limited duration, and considerable maternal mortality. Maternal ART and prolonged breastfeeding while on ART may improve survival, although this has not been reliably quantified.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom